AxoSim - About the company
AxoSim is a series A company based in New Orleans (United States), founded in 2014 by and . It operates as an Advancing nerve-on-a-chip technology to improve drug development.. AxoSim has raised $6.78M in funding from . The company has 29 active competitors, including 14 funded and 1 that has exited. Its top competitors include companies like Emulate, CN Bio and Nortis.
Company Details
AxoSim’s is advancing nerve-on-a-chip technology to improve drug development. Nerve-on-a-chip technology is a 3D cell-based model that acts and functions like a nerve. The technology was developed in the lab of Dr. Michael J. Moore at Tulane University. AxoSim has received funding from the National Science Foundation’s Innovation Corps program.
- Website
- Social
Key Metrics
Founded Year
2014
Location
New Orleans, United States
Stage
Series A
Total Funding
in 11 rounds
Latest Funding Round
Investors
& 10 more
Ranked
4th among 29 active competitors
Employee Count
as on Dec 31, 2022
Similar Companies
Emulate &
Legal entities associated with AxoSim
AxoSim is associated with 1 legal entity given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
---|---|---|---|---|
- | 163 | 805 |
Get your free copy of AxoSim's company profile
AxoSim's funding and investors
AxoSim has raised a total funding of $6.78M over 11 rounds. Its first funding round was on Feb 01, 2016.
Here is the list of recent funding rounds of AxoSim:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
---|---|---|---|---|---|
Nov 08, 2024 | $3.68M | Series A | 4218622 | 3965624 | - |
Sep 09, 2020 | $228K | Grant (prize money) | 2584851 | 9892729 | |
Jun 15, 2020 | $1.97M | Seed | 8519684 | 3288707 |
View details of AxoSim's funding rounds and investors
AxoSim's founders and board of directors
The founders of AxoSim are and . is the CEO of AxoSim.
View details of AxoSim's Founder profiles and Board Members
AxoSim's employee count trend
AxoSim has 27 employees as of Dec 22. The total employee count is 58.8% more than what it was in Dec 21. Here is AxoSim's employee count trend over the years:AxoSim's Competitors and alternates
Top competitors of AxoSim include Emulate, CN Bio and Nortis. Here is the list of Top 10 competitors of AxoSim, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
---|---|---|---|---|---|
1st | Emulate 2013, Boston (United States), Series E | Developer of in vitro models for drug development | $225M | ATEL Capital Group, CSC Upshot VenturesÌý&²¹³¾±è;Ìý | 66/100 |
2nd | CN Bio 2009, Cambridge (United Kingdom), Series B | Develops organ-on-a-chip platforms for drug discovery | $44.8M | , Ìý&²¹³¾±è;Ìý | 61/100 |
3rd | Nortis 2007, Woodinville (United States), Acquired | Developer of platform for generating small segments of human tissues and organs in microfluidic chips | $10.7M | Emerging Technology Partners, Corewell Health VenturesÌý&²¹³¾±è;Ìý | 50/100 |
4th | 2014, New Orleans (United States), Series A | Advancing nerve-on-a-chip technology to improve drug development. | $6.78M | 43/100 | |
5th | Developer of microfluidic devices for industrial applications | $8.89M | 48/100 | ||
6th | ![]() Mepsgen 2019, Seoul (South Korea), Series C | Developer of human organ model chips for pharmaceutical development | $29.3M | E&Investment, Korean Development BankÌý&²¹³¾±è;Ìý | 47/100 |
7th | ![]() Obatala Sciences 2017, New Orleans (United States), Series A | Provider of research enabling products and services to research centers | $3.53M | Springboard Enterprises, Reform VenturesÌý&²¹³¾±è;Ìý | 45/100 |
8th | Mimetas 2013, Leiden (Netherlands), Series B | Develops microfluidics-based organ-on-a-chip tissue models | $28.9M | EIC Fund, Merieux Equity PartnersÌý&²¹³¾±è;Ìý | 45/100 |
9th | Hesperos 2015, Orlando (United States), Funding Raised | Developer of organ-on-a-chip solutions for preclinical testing | - | 43/100 | |
10th | ![]() Cellbox Labs 2020, Riga (Latvia), Seed | Provider of organ-on-chip platform for drug discovery and development | $1.01M | 42/100 |
Looking for more details on AxoSim's competitors? Click to see the top ones
AxoSim's Investments and acquisitions
AxoSim has made no investments or acquisitions yet.
Reports related to AxoSim
Here is the latest report on AxoSim's sector:
View
News related to AxoSim
•
•
•
CMOCRO•Jul 09, 2019•AxoSim
•
CMOCRO•May 30, 2019•AxoSim
•
•
Silicon Bayou Media•Mar 27, 2018•AxoSim
•
Frequently asked questions about AxoSim
When was AxoSim founded?
AxoSim was founded in 2014.Where is AxoSim located?
AxoSim is located in New Orleans, United States.Is AxoSim a funded company?
AxoSim is a funded company, its first funding round was on Feb 01, 2016.When was the latest funding round of AxoSim?
AxoSim's latest funding round was on Nov 08, 2024.What is the annual revenue of AxoSim?
Annual revenue of AxoSim is undefined as on undefined.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies
212K+ Investors
580K+ Funding Rounds
207K+ Acquisitions
2.9K+ Sectors
57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Fine Handling - 2008 founded, Unfunded company
- Pubcare - Fukuoka based, 2020 founded, Unfunded company
- Artesian Scrubbing Bubbles - Martinsville based, Unfunded company
- Three Point O Labs - Hyderabad based, 2022 founded, Unfunded company
- All Klaipeda Hotels - Klaipeda based, 2016 founded, Unfunded company
- Grandmas Jam House - 1995 founded, Unfunded company